SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178913-23-002235
Filing Date
2023-06-20
Accepted
2023-06-20 06:03:03
Documents
1
Period of Report
2023-06-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 6970
  Complete submission text file 0001178913-23-002235.txt   8479
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Issuer) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address TWO COMMERCE SQUARE, 2001 MARKET STREET 28TH FLOOR PHILADELPHIA PA 19103
Business Address
Quigley Jill M. (Reporting) CIK: 0001799780 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38807 | Film No.: 231023210